vs
Side-by-side financial comparison of Noble Corp plc (NE) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $764.4M, roughly 1.5× Noble Corp plc). Noble Corp plc runs the higher net margin — 11.3% vs -127.8%, a 139.1% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -17.6%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $35.4M). Over the past eight quarters, Noble Corp plc's revenue compounded faster (9.5% CAGR vs 1.3%).
Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
NE vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $764.4M | $1.1B |
| Net Profit | $86.6M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 5.6% | -116.0% |
| Net Margin | 11.3% | -127.8% |
| Revenue YoY | -17.6% | -2.5% |
| Net Profit YoY | -10.4% | -3093.9% |
| EPS (diluted) | $0.54 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $764.4M | $1.1B | ||
| Q3 25 | $798.0M | $1.0B | ||
| Q2 25 | $848.7M | $1.1B | ||
| Q1 25 | $874.5M | $1.0B | ||
| Q4 24 | $927.3M | $1.1B | ||
| Q3 24 | $800.5M | $1.1B | ||
| Q2 24 | $692.8M | $1.1B | ||
| Q1 24 | $637.1M | $1.1B |
| Q4 25 | $86.6M | $-1.4B | ||
| Q3 25 | $-21.1M | $7.5M | ||
| Q2 25 | $42.9M | $-8.4M | ||
| Q1 25 | $108.3M | $-6.4M | ||
| Q4 24 | $96.6M | $-44.4M | ||
| Q3 24 | $61.2M | $-21.0M | ||
| Q2 24 | $195.0M | $-108.4M | ||
| Q1 24 | $95.5M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | 5.6% | -116.0% | ||
| Q3 25 | 6.3% | 7.0% | ||
| Q2 25 | 15.9% | 4.3% | ||
| Q1 25 | 21.4% | 4.5% | ||
| Q4 24 | 18.4% | 10.0% | ||
| Q3 24 | 14.4% | 7.4% | ||
| Q2 24 | 30.3% | -2.5% | ||
| Q1 24 | 16.9% | -5.1% |
| Q4 25 | 11.3% | -127.8% | ||
| Q3 25 | -2.6% | 0.7% | ||
| Q2 25 | 5.1% | -0.8% | ||
| Q1 25 | 12.4% | -0.6% | ||
| Q4 24 | 10.4% | -3.9% | ||
| Q3 24 | 7.6% | -1.9% | ||
| Q2 24 | 28.1% | -10.2% | ||
| Q1 24 | 15.0% | 0.2% |
| Q4 25 | $0.54 | $-10.23 | ||
| Q3 25 | $-0.13 | $0.05 | ||
| Q2 25 | $0.27 | $-0.06 | ||
| Q1 25 | $0.67 | $-0.05 | ||
| Q4 24 | $0.56 | $-0.32 | ||
| Q3 24 | $0.40 | $-0.15 | ||
| Q2 24 | $1.34 | $-0.79 | ||
| Q1 24 | $0.66 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $471.4M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.5B | $2.9B |
| Total Assets | $7.5B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $471.4M | — | ||
| Q3 25 | $477.9M | $432.1M | ||
| Q2 25 | $338.2M | $454.2M | ||
| Q1 25 | $303.8M | $409.9M | ||
| Q4 24 | $247.3M | $558.8M | ||
| Q3 24 | $391.9M | $1.5B | ||
| Q2 24 | $162.9M | $542.8M | ||
| Q1 24 | $212.5M | $658.5M |
| Q4 25 | $4.5B | $2.9B | ||
| Q3 25 | $4.5B | $4.4B | ||
| Q2 25 | $4.6B | $4.5B | ||
| Q1 25 | $4.7B | $4.4B | ||
| Q4 24 | $4.7B | $4.3B | ||
| Q3 24 | $4.7B | $4.6B | ||
| Q2 24 | $4.0B | $4.5B | ||
| Q1 24 | $3.9B | $4.7B |
| Q4 25 | $7.5B | $8.5B | ||
| Q3 25 | $7.6B | $10.1B | ||
| Q2 25 | $7.7B | $10.1B | ||
| Q1 25 | $7.9B | $9.8B | ||
| Q4 24 | $8.0B | $9.6B | ||
| Q3 24 | $8.0B | $11.2B | ||
| Q2 24 | $5.6B | $10.4B | ||
| Q1 24 | $5.4B | $10.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $187.1M | $175.4M |
| Free Cash FlowOCF − Capex | $35.4M | $148.6M |
| FCF MarginFCF / Revenue | 4.6% | 13.4% |
| Capex IntensityCapex / Revenue | 19.9% | 2.4% |
| Cash ConversionOCF / Net Profit | 2.16× | — |
| TTM Free Cash FlowTrailing 4 quarters | $432.2M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $187.1M | $175.4M | ||
| Q3 25 | $277.1M | $51.7M | ||
| Q2 25 | $216.4M | $75.9M | ||
| Q1 25 | $271.1M | $-64.5M | ||
| Q4 24 | $136.2M | $312.6M | ||
| Q3 24 | $283.8M | $42.2M | ||
| Q2 24 | $106.8M | $9.5M | ||
| Q1 24 | $128.7M | $-1.4M |
| Q4 25 | $35.4M | $148.6M | ||
| Q3 25 | $139.5M | $29.8M | ||
| Q2 25 | $99.8M | $56.7M | ||
| Q1 25 | $157.5M | $-90.0M | ||
| Q4 24 | $-4.4M | $274.9M | ||
| Q3 24 | $156.8M | $15.1M | ||
| Q2 24 | $-34.3M | $-18.9M | ||
| Q1 24 | $-37.9M | $-26.5M |
| Q4 25 | 4.6% | 13.4% | ||
| Q3 25 | 17.5% | 2.9% | ||
| Q2 25 | 11.8% | 5.4% | ||
| Q1 25 | 18.0% | -8.6% | ||
| Q4 24 | -0.5% | 24.2% | ||
| Q3 24 | 19.6% | 1.4% | ||
| Q2 24 | -4.9% | -1.8% | ||
| Q1 24 | -6.0% | -2.4% |
| Q4 25 | 19.9% | 2.4% | ||
| Q3 25 | 17.3% | 2.1% | ||
| Q2 25 | 13.7% | 1.8% | ||
| Q1 25 | 13.0% | 2.4% | ||
| Q4 24 | 15.2% | 3.3% | ||
| Q3 24 | 15.9% | 2.5% | ||
| Q2 24 | 20.4% | 2.7% | ||
| Q1 24 | 26.2% | 2.3% |
| Q4 25 | 2.16× | — | ||
| Q3 25 | — | 6.89× | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 2.50× | — | ||
| Q4 24 | 1.41× | — | ||
| Q3 24 | 4.64× | — | ||
| Q2 24 | 0.55× | — | ||
| Q1 24 | 1.35× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NE
| Floaters | $559.8M | 73% |
| Jackups | $145.5M | 19% |
| Service Other | $59.1M | 8% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
